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ABSTRACT
Objective: To analyze seizure outcome in individuals with familial mesial temporal lobe epilepsy (FMTLE).
Method: We followed prospectively 64 individuals with FMTLE and 37 asymptomatic individuals belonging
to 28 families. Results: Patients with FMTLE had a mean follow up was 93.4 ± 15.8 months. At baseline
they were divided in benign (n = 29), remission (n = 28) and refractory (n = 7). At last follow up visit
41.4% patients with benign FMTLE remained classified as benign, 20.7% became refractory and 37.9% were
in remission. In the subgroup of FMTLE in remission 21 75% remained without seizures; 21.4% were classified
as benign FMTLE, and one died (3.6%) from cause unrelated to epilepsy. All refractory patients remained
refractory. From the asymptomatic group, 10.8% became symptomatic (FMTLE). The mean follow up was
76.0 ± 21.2 months. Conclusion: Prospective follow up of more than 7 years in patients with FMTLE
revealed that it is unlikely to achieve seizure control in those with refractory seizures. Patients with diagnose
of more benign forms of FMTLE for more than one year are likely to either remit or remain under well
controlled seizures. The majority of patients who had achieved seizure remission remained seizure-free and
none became refractory. Asymptomatic individuals had a greater probability to have seizures compared to
the general population in a 6 year period of follow up.
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RESUMO
Evolução da epilepsia de lobo temporal mesial familiar
Objetivos: Analisar a evolução de famílias com epilepsia de lobo temporal mesial familiar (ELTMF).
Metodologia: Seguimento prospectivo de 64 pacientes com ELTMF e 37 membros assintomáticos perten-
cente a 28 famílias. Resultados: A média de seguimento dos pacientes com ELTMF foi de 93,4 ± 15,8
meses. Na avaliação inicial os pacientes foram divididos em benignos (n = 29), remissão (n = 28) e refratá-
rios (n = 7). Na última visita disponível, 41,4% dos pacientes com ELTMF benigna permaneceram classifi-
cados como benignos, 20,7% tornaram-se refratários e 37,9% entraram em remissão. No grupo em remissão,
75% permaneceram livres de crise, 21,4% foram classificados como benignos e um faleceu (3,6%) de causa
não relacionada à epilepsia. Todos pacientes refratários permaneceram refratários. Em relação aos assin-
tomáticos 10,8% evoluíram com crises. A média de seguimento dos assintomáticos foi de 76,0 ± 21,2 meses.
Conclusão: O seguimento prospectivo de mais de 7 anos de pacientes com ELTMF revelou que é imprová-
vel ocorrer controle de crises no grupo refratário. No grupo benigno é muito provável que estes indivíduos
entrem em remissão ou permaneçam com evolução benigna. A maioria dos pacientes do grupo em remissão
permaneceu em remissão e nenhum se tornou refratário. Em relação aos assintomáticos a probabilidade de
apresentar uma crise no decorrer de aproximadamente 6 anos foi maior que o observado na população geral.
Unitermos: Epilepsia, lobo temporal, familiar, crises.
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INTRODUCTION
Familial mesial temporal lobe epilepsy (FMTLE) has
been described as a well characterized syndrome, with
different degrees of seizure severity, with the majority of
patients having good seizure control. However, there has
been no report of long term follow up of FMTLE.
The best definition of FMTLE is based on the familial
recurrence of mesial temporal lobe epilepsy (MTLE) in the
absence of any suggestion of other partial (including late-
ral TLE symptoms) or generalized epilepsy syndromes in
other affected family members.1,3,4,5 The finding of at least
two MTLE patients in one family is suggestive of FMTLE.
The observation of an autosomal dominant inheritance
pattern with incomplete penetrance implies the presence
of asymptomatic carriers of the genetic abnormalities, who
can transmit the disease to their offspring. Therefore, we
should consider inclusion of families not only with affected
first-degree relatives, but also those with affected second
and third degree relatives. This criterion has not been
employed in some reported series, leading to exclusion of
many possible FMTLE kindreds.6
The purpose of this study was to analyze seizure out-
come in individuals with FMTLE.
METHODS
We followed prospectively 64 individuals with clinical
diagnose of FMTLE from 28 families and 37 asymptomatic
patients (first or second degree relatives from families with
FMTLE). Seizures and epilepsy syndromes were classified
according to the ILAE. Patients who fulfilled the clinical
criteria for FMTLE were divided into three groups,
according to seizure outcome: Remission: seizure free for
at least two years; Benign: patients, with less than six
complex partial seizures (CPS) per year and no more than
two secondary generalized tonic-clonic seizures per year;
and Refractory: more than six CPS per year despite
adequate anti-epileptic drugs (AEDs). Patients who did
not fulfilled criteria for MTLE or who underwent epilepsy
surgery (n = 16) during this follow up were excluded from
this study.
RESULTS
Patients with FMTLE had a mean follow up of
93.4 ±15.8 months (mean ± SD; ranging from 45 to 121.9
months). The mean baseline duration of epilepsy was
28.7 ±15.3 years ranging from 1 to 62 years. At baseline
they were divided in benign (n = 29), remission (n = 28)
and refractory (n = 7). Patients who have been submitted
to epilepsy surgery (n=16) during this follow up were not
included in this study. At last follow up visit 12 (41.4%)
patients with benign FMTLE remained classified as benign,
6 (20.7%) became refractory, 11 (37.9%) were in remission.
In the subgroup of FMTLE in remission 21 (75%)
remained without seizures; 6 (21.4%) were classified as
benign FMTLE, and one died (3.6%) from cause unrelated
to epilepsy. All refractory patients remained refractory.
From the asymptomatic group, 4 (10.8%) became sympto-
matic (FMTLE). The mean follow up was 76.0 ± 21.2
months (mean ± SD; ranging from 34.7 to 94.73 months).
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Figure 1. Long term follow up of familial mesial temporal lobe
epilepsy.
DISCUSSION
This work in progress suggests that patients with
FMTLE presenting with refractory seizures are unlikely to
remit in a short term follow up. Patients with more benign
forms of FMTLE for more than one year are likely to
either remit or remain under well controlled seizures. The
majority of patients who had achieved seizure remission
remained seizure-free and none became refractory.
Asymptomatic individuals had a greater probability to have
seizures compared to the general population in a 6 year
period of follow up.2 Whether patients with benign
FMTLE are more likely to remit than patients with
sporadic MTLE secondary to hippocampal sclerosis remains
to be investigated. Further analyses and comparison with
a cohort of patients with sporadic MTLE are necessary to
confirm these preliminary observations.
Table 1. Summary of frequencies in each clinical group at
baseline and at last follow up.
Baseline 
Follow up 
Asymptomatic Remission Benign Refractory 
Asymptomatic 89,2% 0% 0% 0% 
Remission 0% 75% 37,9% 0% 
Benign 10,8% 21,4% 41,4% 0% 
Refractory 0% 0% 20,7% 100% 
Death 0% 3,6% 0% 0% 
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